The authors have disclosed that they have no financial interests, arrangements, affiliations, or commercial interests with the manufacturers of any products discussed in this article or their competitors.
Research reported in this publication was supported by the NCI of the NIH under Award Number P30CA016056. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.
American Cancer Society. Cancer Facts & Figures 2014. Available at: http://www.cancer.org/acs/groups/content/@research/documents/webcontent/acspc-042151.pdf. Accessed October 10 2016.
PartinAWKattanMWSubongENP. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA1997;277:1445–1451.
StephensonAJScardinoPTEasthamJA. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol2005;23:7005–7012.
KattanMWWheelerTMScardinoPT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol1999;17:1499.
SwansonGPYuCKattanMW. Validation of postoperative nomograms in prostate cancer patients with long-term follow-up. Urology2011;78:105–109.
BiancoFJJrKattanMWScardinoPT. Radical prostatectomy nomograms in black American men: accuracy and applicability. J Urol2003;170:73–77.
GraefenMKarakiewiczPICagiannosI. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol2002;20:951–956.
ChoYJungSChoN. Impact of international variation of prostate cancer on a predictive nomogram for biochemical recurrence in clinically localised prostate cancer. World J Urol2014;32:399–405.
KattanMWVickersAJYuC. Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer2009;115:1005–1010.
MohlerJLArmstrongAJBahnsonRR. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 32016. Accessed March 10 2015. To view the most recent version of these guidelines visitNCCN.org.
HarrellFELeeKLMarkDB. Tutorial in biostatistics: multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med1996;15:361–387.
ThompsonIThrasherJBAusG. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol2007;177:2106–2131.
MohlerJLArmstrongAJBahnsonRR. Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw2012;10:1081–1087.
HeidenreichABastianPJBellmuntJ. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013. Eur Urol2014;65:124–137.